Jan 11, 2023 07:02 PM

BUSINESS

Vaccine-Maker CanSino Bio Plans Swiss Listing

What’s new: Vaccine-maker CanSino Biologics Inc. (688185.SH/6185.HK) is planning to issue global depositary receipts (GDRs) and float the securities on the SIX Swiss exchange, according to a Tuesday exchange filing.

Through the listing, the Chinese company hopes to tap new international financing channels, while improving its international brand to help with its overseas business development.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: China Celebrates Golden Week

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio

00:00

00:00/00:00

MOST POPULAR

1: Caixin Explains: What China’s New Five-Year Plan Says About the Economy

2: Cover Story: Trade War Deepens as U.S. and China Open New Fronts at Sea and in Silicon

3: Beijing Fast-Tracks $42 Billion Through Policy Banks to Revive Growth

4: Interview: HKMA’s Fintech Chief on Forging Hong Kong’s Digital Asset Future

5: Update: China’s Quarterly GDP Growth Slows to 4.8% as Weak Consumption Weighs

SPONSORED

OR